|Table of Contents|

Research progress of transcriptin regulator GATA6 in tumor

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 06
Page:
955-957
Research Field:
Publishing date:

Info

Title:
Research progress of transcriptin regulator GATA6 in tumor
Author(s):
Zhao WeiZhao YanbinZhang ShiboWang Yan
Department of Medical Oncology,The Affiliated Tumor Hospital of Harbin Medical University,Heilongjiang Harbin 150081,China.
Keywords:
GATA6GATA familytumors
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2018.06.035
Abstract:
GATA6 belongs to the GATA family.GATA6 plays a different biological role in different tumor types.GATA6 acts as a gene for cancer in cholangiocarcinoma and breast cancer.GATA6 is a tumor suppressor gene in ovarian cancer and pancreatic cancer.This review focuses on the characteristics of GATA6 and its family members,and their relationship with related tumors.

References:

[1]Carrasco M,Delgado I,Soria B,et al.GATA4 and GATA6 control mouse pancreas organogenesis[J].J Clin Invest,2012,122(10):3504-3515.
[2]Mehta A,Cordero J,Dobersch S,et al.Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate[J].EMBO Mol Med,2016,8(12):1380-1389.
[3]Tata PR,Rajagopal J.Plasticity in the lung:Making and breaking cell identity[J].Development,2017,144(5):755-766.
[4]Li C,Cai J,Pan Q,et al.Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium[J].Biochem Biophys Res Commun,2000,270(2):462-468.
[5]Chen Y,Yang L,Cui T,et al.HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer[J].J Pathol,2015,235(3):397-407.
[6]Cheung WK,Zhao M,Liu Z,et al.Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis[J].Cancer Cell,2013,23(6):725-738.
[7]Mosconi S,Beretta GD,Labianca R,et al.Cholangiocarcinoma[J].Crit Rev Oncol Hematol,2009,69(3):259-270.
[8]Tian F,Li D,Chen J,et al.Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma[J].Eur J Cancer,2013,49(7):1771-1780.
[9]Kayhanian H,Smyth EC,Braconi C.Emerging molecular targets and therapy for cholangiocarcinoma[J].World J Gastrointest Oncol,2017,9(7):268-280.
[10]Wu C,Liu Z,Ma L,et al.MiRNAs regulate oxidative stress related genes via binding to the 3' UTR and TATA-box regions:A new hypothesis for cataract pathogenesis[J].BMC Ophthalmol,2017,17(1):142.
[11]Massillo C,Dalton GN,Farré PL,et al.Implications of microRNA dysregulation in the development of prostate cancer[J].Reproduction,2017,154(4):R81-R97.
[12]Hao C,Xu X,Ma J,et al.MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1[J].Oncol Lett,2017,13(4):2071-2078.
[13]Tian F,Chen J,Zheng S,et al.miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis[J].BMC Cancer,2017,17(1):175.
[14]Li D,Chen J,Gao Z,et al.67-kDa laminin receptor in human bile duct carcinoma[J].Eur Surg Res,2009,42(3):168-173.
[15]Pesapane A,Ragno P,Selleri C,et al.Recent advances in the function of the 67 kDa laminin receptor and its targeting for personalized therapy in cancer[J].Curr Pharm Des,2017,(32):4745-4757.
[16]Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[17]Kwei KA,Bashyam MD,Kao J,et al.Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer[J].Plos Genet,2008,4(5):e1000081.
[18]Del RM,Vivaldi C,Rofi E,et al.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer[J].Sci Rep,2017,7(1):7931.
[19]Martinelli P,Madriles F,Caamero M,et al.The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice[J].Gut,2016,65(3):476-486.
[20]Martinelli P,Carrillo-de SPE,Cox T,et al.GATA6 regulates EMT and tumour dissemination,and is a marker of response to adjuvant chemotherapy in pancreatic cancer[J].Gut,2017,66(9):1665-1676.
[21]Wallesch M,Pachow D,Blücher C,et al.Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas[J].J Neurol Sci,2017,380:112-121.
[22]Song Y,Tian T,Fu X,et al.GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial-mesenchymal transition by upregulating slug expression[J].Exp Mol Pathol,2015,99(3):617-627.
[23]Tsai SC,Huang SF,Chiang JH,et al.The differential regulation of microRNAs is associated with oral cancer[J].Oncol Rep,2017,38(3):1613-1620.
[24]Deng L,Liu H.MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6[J].Int J Clin Exp Med,2015,8(2):1862-1870.
[25]Kamnasaran D,Qian B,Hawkins C,et al.GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model[J].Proc Natl Acad Sci USA,2007,104(19):8053-8058.
[26]Soozangar N,Sadeghi MR,Jeddi F,et al.Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer[J].J Cell Physiol,2017,10:1-14.
[27]Cecener G,Tunca B,Egeli U,et al.The promoter hypermethylation status of GATA6,MGMT,and FHIT in glioblastoma[J].Cell Mol Neurobiol,2012,32(2):237-244.
[28]Skiriute D,Vaitkiene P,Saferis V,et al.MGMT,GATA6,CD81,DR4,and CASP8 gene promoter methylation in glioblastoma[J].BMC Cancer,2012,12:218.
[29]Seton-Rogers S.Tumorigenesis:Fitness penalties of aneuploidy[J].Nat Rev Cancer,2017,17(3):142-143.
[30]Capo-chichi CD,Cai KQ,Testa JR,et al.Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer[J].Mol Cell Biol,2009,29(17):4766-4777.

Memo

Memo:
National Natural Science Foundation of China(No.81673042);国家自然科学基金(编号:81673042);海燕科研基金(编号:JJZD2017-06)
Last Update: 2018-01-29